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β-hairpinA) mediates protein interactions driving the assembly of both immature viral
particles and the core of the mature virions. Structurally conserved N-terminal domains of several
retroviruses refold after proteolytic cleavage into a β-hairpin, stabilized by a salt bridge between conserved
N-terminal Pro and Asp residues. Based on comparison with other retroviral CA, we identiﬁed Asp50 and
Asp57 as putative interacting partners for Pro1 in Mason-Pﬁzer monkey virus (M-PMV) CA. To investigate the
importance of CA Pro1 and its interacting Asp in M-PMV core assembly and infectivity, P1A, P1Y, D50A, T54A
and D57A mutations were introduced into M-PMV. The P1A and D57A mutations partially blocked Gag
processing and the released viral particles exhibited aberrant cores and were non-infectious. These data
indicate that the region spanning residues Asp50–Asp57 plays an important role in stabilization of the
β-hairpin and that Asp57 likely forms a salt-bridge with P1 in M-PMV CA.
© 2008 Elsevier Inc. All rights reserved.IntroductionAssembly of retroviruses is driven by polymerization of Gag
polyproteins, either at the plasma membrane (lentiviruses, alpha-
viruses, gammaretroviruses) or at a distinct place within the infected
cells (betaretroviruses). Immature spherical particles bud through the
plasma membrane and the viral protease concomitantly cleaves Gag
polyprotein precursors into discrete proteins. Three of these structural
proteins, matrix (MA), capsid (CA) and nucleocapsid (NC) are common
to all retroviruses and rearrange to form the mature, infectious virion.
In mature virions theMA remains associated with the viral membrane
and CA forms a protein shell surrounding a viral genomic RNA and NC
complex.
During the assembly of immature viral particles the CA domain
is thought to mediate Gag–Gag interactions (Gamble et al., 1997;
Ganser-Pornillos et al., 2004; Kingston et al., 2000; Mortuza et al.,
2004; von Schwedler et al., 2003). Although retroviral CA proteins
exhibit a signiﬁcant sequence similarity only in a short domain
known as the major homology region, all high-resolution 3-D
retroviral CA structures solved to date are remarkably similard at fax: +420 220183556. M.
logy and Center of Applied
Technická 3, 166 28 Prague,
rumlova@uochb.cas.cz
l rights reserved.(Gamble et al., 1996; Campos-Olivas et al., 2000; Jin et al., 1999;
Khorasanizadeh et al., 1999; Gamble et al., 1997; Gitti et al., 1996;
Kingston et al., 2000; Cornilescu et al., 2001; Mortuza et al., 2008).
The capsid proteins are composed of two independently folded
domains that are connected by short ﬂexible linkers (Gamble et al.,
1996; Momany et al., 1996; Gitti et al., 1996). The N-terminal
domain (NTD) is composed of a β-hairpin followed by seven α-
helices and the C-terminal dimerization domain (CTD) consists of
four α-helices. All mature retroviral capsids except that of foamy
virus contain N-terminal β-hairpin loops (HIV-1 (Human immuno-
deﬁciency virus) Pro1-Gln13, RSV (Rous sarcoma virus) Pro1-Thr12,
and MLV (Murine leukemia virus) Pro1-Trp13). These loops are
formed upon capsid maturation, during which cleavage releases the
imino-group of Pro1, which is stabilized by formation of a salt
bridge with a highly conserved aspartate (in HIV-1, RSV, MLV) or
glutamate (in BIV, EIAV) (von Schwedler et al., 1998). Point mut-
ations throughout this region block the in vitro assembly of HIV-1
capsid protein, HIV-1 core assembly in vivo and infectivity of HIV-1
(Abdurahman et al., 2007; Gross et al., 1998; Leschonsky et al.,
2007; von Schwedler et al., 1998). A high-resolution structure of
MLV capsid hexameric amino-terminal domain revealed that β-
hairpins from each monomer are located at the center of the
hexamer and form the wall of the central channel together with
residues 14–16, thereby stabilizing and orienting residues involved
in inter-subunit contacts (Mortuza et al., 2004). Recently, using
electron microscopy and image reconstruction, it was conﬁrmed
that the hexameric rings are formed by CA-NTDs and stabilized by
Fig.1. Immunoprecipitation of cell- and virion-associated viral protein. COS-1 cells were
transfected with wild-type or mutant proviral genome (P1A, P1Y, D50A, T54A, D57A).
The cells were pulse-labeled with [35S] methionine for 30 min (panel A) and chased for
4 h (B). The culture medium containing extracellular virions from the cells after a 4-h
chase was ﬁltered through a 0.45 µm ﬁlter (C). Viral-speciﬁc proteins were
immunoprecipitated both from the cell lysates and culture media with a polyclonal
rabbit anti-M-PMV CA antiserum. Proteins were separated on a 12% SDS-polyacryla-
mide gel. Molecular weight standards: 20, 25, 37, 50, 75, 100, 150 and 250 kDa.
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et al., 2007).
Mason-Pﬁzer monkey virus (M-PMV), a member of the betare-
trovirus family, assembles its immature capsids in the cytoplasm. After
proteolytic cleavage the Gag polyprotein yields six structural proteins
MAp10, phosphoprotein pp24, p12, CAp27, NCp14, and p4. Previous
studies suggested that the N-terminal proline of M-PMV CA plays a
key role in determining the particle shape. In E. coli the (ΔPro)CA-NC
fusion protein lacking this P1 assembles into spherical particles rather
than the sheets assembled by the CA-NC protein. Moreover, as with
HIV (Gross et al., 1998; von Schwedler et al., 1998), merely extending
the N-terminus of M-PMV CA by one amino acid is sufﬁcient to induce
the assembly of spherical particles (Rumlova-Klikova et al., 2000).
In contrast to the extensive mutational analysis performed on HIV-
1 CA, the only one work concerning M-PMV CA has been published
(Strambio-de-Castillia and Hunter, 1992). In order to investigate the
contribution of the N-terminal proline and its putative interacting
partner to core formation, we generated a series of mutations either of
the N-terminal proline (P1A, P1Y) or within the region where the
putative salt-bridge formation might occur (D50A, T54A, D57A).
Here we report the necessity of both the N-terminal proline and
the aspartate residue in position 57 of CA protein for proper
processing of Gag polyprotein, viral core formation and infectivity.
These results suggest that in M-PMV CA the N-terminal β-hairpin is
most probably stabilized by a salt bridge between these two residues
and that substitution of some amino acid residues in the proximity
dramatically reduces the infectivity.
Results
Virus production and maturation
Based on our previous results on the role of the N-terminal proline
residue of CA in directing particle shape (Rumlova-Klikova et al., 2000)
and on analogies with other viruses, we hypothesized that M-PMV
NTD CA is stabilized by an interactionwith some of the inner aspartate
residues. To verify this and to determine which residues in M-PMV
NTD contribute to the formation and stabilization of the β-hairpin and
thereby the intermolecular contacts between CA proteins, ﬁveM-PMV
mutants were prepared and analyzed. Pro1 (P1), Asp50 (D50), and
Asp57 (D57) were individually replaced with alanine residues.
Moreover, threonine, located two amino acids upstream of the most
conserved Asp retroviral residue in CA (T48 in HIV, T51 in HTLV-1, T64
in MMTV, T49 in EIAV), was also replaced with alanine (T54A). P1 was
also mutated to tyrosine, since Tyr is known to be present in position
P1 of protease recognition sites (Pettit et al., 2002). The phenotypic
effects of these mutations were assayed in COS-1 cells transfected
with the wild-type and mutant proviral constructs. The intracellular
levels and ratios of polyprotein precursors Pr78Gag, Pr 95Gag-Pro, and
Pr180Gag-Pro-Pol synthesized during the pulse period were comparable
for the wild-type and all the mutants (Fig. 1A). After a 4-h chase, the
mature capsid protein (27 kDa) was the predominant band in all cell
lysates, except that from cells expressing the D57A mutant, in which
several distinct CA-related intermediates of approximate molecular
weights 35, 40, and 48 kDa appeared (Fig.1B). The characteristic
wild-type like processing pattern of Gag polyprotein was observed in
released particles of the P1Y, D50A, and T54A mutants (Fig. 1C). The
CA-related intermediates, identical to those detected in the cells
transfected with the D57A mutant, were also present in released
D57A mutant particles, and low amounts of these products were
observed in P1A particles (Fig. 1C, lanes 4 and 8). Moreover, a capsid
protein cleavage product of molecular weight 20 kDa was also
detected in both P1A and D57A (Fig. 1C, lanes 4 and 8). Similar
results indicating altered processing of the P1A and D57A mutants
were obtained by Western blot analysis of viral particles released
48 h post-transfection (Fig. 2A, lanes 3 and 7). Western blots of these
Fig. 2.Western blot analysis of released viruses. COS-1 cell were transfected with wild-
type or mutant proviral DNAs. Viruses were harvested 48 h post-transfection and
pelleted through a 20% sucrose cushion. The viral pellets were resuspended in protein
loading buffer. Proteins were resolved using SDS-PAGE, and M-PMV related proteins
were detected by rabbit antibodies against CA (A) and MA, dUTPase, PR, RT and IN (B).
Fig. 3. Release and processing of wild-type and CA mutants. The percent of CA-related
proteins released in the medium after a 4-h chase: p27CA (grey part of bars) and p20CA,
p35CA, p40CA, and p48CA (black part of bars). COS-1 cells were transfected with wild-
type or P1A, P1Y, D50A, T54A, or D57A mutant M-PMV proviral genome, metabolically
labeled with [35S] methionine, and immunoprecipitated from themedium 4 after chase.
Proteins were separated by SDS-PAGE and the gel was imaged using phosphor screen
(Typhoon). The quantiﬁcation of CA-related band intensities for p27CA, p35CA, p40CA,
p48CA, and p20CA was carried out using OptiQuant software. The sum of CA intensities
of the wild-type virus was considered to be 100%.
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the additional CA-derived proteins of higher molecular weights (35,
40, and 48 kDa) and to the truncated CA protein (molecular weight
20 kDa). For better characterization of these Gag-processing
intermediates, Western blots of samples of the released particles
48 h post-transfection were probed with antibodies speciﬁc to MA,
p12 and NC. Mature matrix protein of correct molecular weight
(p10MA) was observed in all mutants in amounts similar to the wild-
type and the anti-MA antibody did not react with any of Gag
cleavage intermediates (Fig. 2B). The analysis of partially processed
Gag revealed the presence of NC in all three intermediates, and the
p12 protein was also found in the band corresponding to proteins of
molecular weight 48 kDa. To analyze whether the processing of the
Gag-Pro or Gag-Pro-Pol polyproteins was not affected, Western blot
using antibodies against dUTPase, protease (PR17, PR12), reverse
transcriptase (RT) and integrase (IN) was performed (Fig. 2B). No
difference in the processing of Pro-Pol region was observed between
the mutant and the wild-type viruses (Fig. 2B). According to this data
we can surmise that the Gag-processing intermediates p35, p40, and
p48 correspond to CA-NC, CA-NC-p4, and p12-CA-NC fusion proteins.
The p20 protein was recognized by a monoclonal antibody against
the C-terminal part of CA, suggesting that the internal cleavage of CA
occurs within its N-terminal part. The altered cleavage pattern of
mutants P1A and D57A (Fig. 2 lanes 3 and 7), both identiﬁed to have
partially blocked Gag polyprotein processing and internal cleavage
within CA, suggested a change in the overall fold of the CA and
adjacent regions. The T54A mutation did not prevent processing of
Gag polyprotein; however, a truncated 20 kDa form of CA was
detected in the pelleted virus (Fig. 2, lane 6).
Kinetic analysis and processing of the wt and D57A mutant
Since the initial pulse–chase experiments presented in Fig. 1
addressed only a single time point and did not provide informationon the efﬁciency of the processing or the rate of turnover of
unprocessed intermediates, we performed time–course pulse–chase
experiments with the wild-type and P1A, P1Y, D50A, T54A, and D57A
mutant proviral constructs. Transfected COS-1 cells were metaboli-
cally labeled and chased for 1, 4, 8, and 24 h. The virus-speciﬁc
proteins were immunoprecipitated using rabbit anti M-PMV CA
antiserum, and the CA-related band intensities for p20CA, p27CA,
p35CA, p40CA, and p48CA were quantiﬁed. The total amounts of
released capsid proteins for each construct were considered to be the
sums of the virus-associated p27CA (grey part of bars Fig. 3) and the
improperly processed CA-related p20CA, p35CA, p40CA, and p48CA
proteins (black part of bars Fig. 3). The relative amounts of released
CA-related proteins of individual mutants were compared to that of
the wild-type, which was regarded as 100%. The P1Y mutant was
released with efﬁciency comparable to the wild-type (more than 90%
of the wt); slightly lower efﬁciency (about 80%) was observed for the
P1A mutant and about 70% wt efﬁciency was observed for the T54A,
D50A, and D57A mutants. The release of the D57A mutant increased
slower in comparison to that of the wild-type as after 8 h chase
period only 40% of wt level of extracellular particles was observed;
this level remained constant for an additional 16 h (data not shown).
However, only about 15% of virus-associated capsid protein p27CA
properly processed from Gag polyproteins was detected in the D57A
mutant (see Fig. 3), and this ratio did not change over the time period
of the experiment. Similarly, the amounts and proportions of CA to
CA-related products of incomplete cleavage of the P1A, P1Y, D50A,
and T54A Gag mutants did not change over the chase period,
suggesting that these CA-related intermediates are not products of
non-speciﬁc Gag degradation.
Infectivity
The infectivity was determined by a single-round infectivity assay
using the EGFP protein as a reporter in an assay described by Stansell
et al. (2007). The virus-like particles (VLPs) released from the
transfected cells were normalized based on quantiﬁcation of reverse
transcriptase activity. According to this assay no signiﬁcant differ-
ences among the wild-type and the mutant VLPs were observed,
suggesting that both wild-type and mutant virus particles are
released with similar efﬁciency. Equivalent amounts of VLPs were
used for infection of fresh COS-1 and 293T cells. The multiplicity of
infection was analyzed by ﬂow cytometry 48 h post-infection. The
Fig. 4. Relative infectivity of M-PMV wild-type and P1A, P1Y, D50A, T54A, and D57A
mutants analyzed by a single-round infectivity assay. COS-1 cells were transfected with
the wild-type or mutant pSARM-EGFP and the pTMO vector. 48 h post-transfection the
virions released into the media were ﬁltered and normalized by RT assay. Equivalent
amounts of virions were used for infection of fresh COS-1 cells. 48 h post-infection the
percentage of GFP-expressing cells was determined by ﬂow cytometry cell sorter
analysis.
160 M. Wildová et al. / Virology 380 (2008) 157–163results from three independent infectivity determinations for the
wild-type and the mutants are summarized in Fig. 4. The percentage
of EGFP positive cells i.e. those infected with recombinant virus
ranged between 30–35% for the wild-type and below 0.5% for the
negative control. The relative infectivity for the wild-type was
regarded as 100%. Interestingly, even the mutants D50A and T54A,
which exhibited wild-type like kinetics of processing of Gag
polyprotein, with the wild-type level of properly processed p27CA,
showed a defect in the single-round infectivity assay and exhibited
approximately 20% and 12% of the wild-type infectivity, respectively.
The mutants with incomplete processing, P1A and D57A, and the P1Y
mutant were non-infectious.Fig. 5. Electronmicrographs of the COS-1 cells expressing the wild-type andM-PMV CAmuta
observed particle is summarized below:
Construct Number of immature
intracytoplasmic particles
Wild-type 104
P1A 14
P1Y 28
D50A 49
T54A 15
D57A 49Particle morphology
The impaired processing of the P1A and D57A mutants, which do
not yield mature p27CA, suggested that these mutations might affect
mature core formation rather than the assembly of immature
particles. To analyze this hypothesis, we carried out electron
microscopic studies of thin sections of COS-1 cells transfected with
the wild-type and mutant proviral constructs (Fig. 5). The overall
appearance of the immature intracellular particles within the cells
producing wild-type was very similar to those of the cells expressing
the mutants. In these cells transfected with the wild-type, P1A, P1Y,
D50A, T54A, and D57A mutants, both individual preassembled
immature intracellular particles and clusters of particles accumulating
at a distinct site in proximity to the nucleus and at the plasma
membrane in the stage of budding were observed (data not shown).
Released VLPs were observed for both wild-type and all mutants
examined. The mutations P1Y, D50A, and T54A did not alter the viral
particle morphology and the mature cores revealed the same size and
shape as was observed for the wild-type (Fig. 5). In contrast, the
mutants with affected Gag polyprotein processing showed defects in
virus morphology. In the case of the P1A mutant oversized and mostly
elongated particles with double or irregularly shaped cores were
observed (Fig. 5). Similarly, released D57A particles did not contain
characteristic cores; they harbored packed electron-dense material
instead (Fig. 5). To compare the size and the density of these P1A and
D57A aberrant VLPs to that of the wild-type, centrifugation in an
iodixanol gradient was performed. First, the VLPs released from COS-1
cells expressing the wild-type, P1A, and D57A CA were concentrated
from the media by sedimentation onto a 60% cushion of iodixanol.
Next, the viral particles were separated by gradient centrifugation
(continuous 10–40% iodixanol gradient) and their distribution was
analyzed by Western blot. This experiment revealed that the wild-
type and D57A VLPs sedimented at a density of 1.11–1.14 g/ml,
whereas the P1AVLPs sedimented at a density of 1.13–1.15 g/ml. Thesents P1A, P1Y, D50A, T54A and D57A. Scale bars are 100 nm in all panels. Statistics data of
Mature particles
Regular particles/(%) Irregular % (number)
64/(100) 0
2/(33) 4/(67)
7/(100) 0
11/(85) 2/(15)
28/(100) 0
0 19/(100)
161M. Wildová et al. / Virology 380 (2008) 157–163data are in an agreement with the EM observation, where VLPs
released from the P1A expressing cells appeared to be larger in
comparison to the wild-type and often contained double cores.
Discussion
As a result of processing, the N-terminal domain of retroviral CA
refolds into a β-hairpin, stabilized by a salt bridge. This interaction
is mediated by the N-terminal proline (Pro1) and an aspartate
residue (Asp 51 in HIV-1 CA, Asp 52 in RSV, Asp 54 in MLV, Asp 54
in HTLV-1) that are both highly conserved among the retroviral CA
proteins. M-PMV CA contains two potential candidates for the
interaction with P1. Since the three-dimensional structure of M-PMV
CA-NTD has not yet been solved, both D50 and D57 remain equally
suitable partners for the interaction with Pro1 and stabilization of
the β-hairpin.
Experiments with proviral M-PMV constructs showed that the
levels of Gag polyprotein synthesized in transfected COS-1 cells were
similar for all themutants tested and did not differ from that seenwith
the wild-type. The Gag polyprotein in released particles was readily
processed to effectively liberate its N-terminal MA protein, which was
detected in all mutants and the wild-type. This was expected as
previously described in vitro experiments simulating the activation of
M-PMVprotease demonstrated thatM-PMVGagprocessing is initiated
by the liberation of matrix protein and phosphoprotein (pp24) (Parker
and Hunter, 2001). In addition, it could be anticipated that structural
changes in the CA domain would not affect the relatively distant
cleavage at the N-terminus of Gag; in contrast to HIV-1, M-PMVMA is
separated by two other proteins (pp24 and 12) from CA. In contrast to
MA, theM-PMVCA proteinwas not released efﬁciently fromwild-type
Gag in vitro (Parker and Hunter, 2001). Moreover, the fusion protein
CA-NC was not completely processed by M-PMV PR even during 48 h
in vitro incubation (Rumlova et al., 2003). These results contrast with
the in vivo experiments described in this work, in which complete
processing of full length CA protein (p27) was observed both in the
wild-type released particles and for the P1Y, D50A, and T54Amutants.
However, in cells transfected with the P1A and D57A mutants the
presence of persistent intermediates of Gag proteolytic processingwas
observed, indicating that D57A affects the accessibility of the p12/CA
cleavage site. Comparison of the proteolytic products of P1Y and P1A
justiﬁes our assumption that tyrosine substitution for proline in the P1′
position will preserve the protease cleavage site. Indeed, this
replacement (p12PKDIF⁎PVTETCA, p12PKDIF⁎YVTETCA) had no effect on
the proteolytic cleavage of mutated Gag polyprotein; the P1Y mutant
underwent processing similar to that of the wild-type. The N- and C-
terminally extended CA-related intermediates of Gag processing
observed in the P1A and D57A mutants were identiﬁed as CA-NC
(p35), CA-NC-p4 (p40) and p12-CA-NC (p48) using antibodies speciﬁc
to M-PMV NC and p12. It is likely that preventing the proteolytic
cleavage in p12⁎CA negatively affects further cleavage in CA⁎NC. This is
consistent with the data published by Auerbach et al. (2007), who
identiﬁed theGag-processing intermediates as CA-NC, p12-CA-NC, and
MA-p12-CA in MoMLV with an insertion mutation inhibiting the
cleavage at the N-terminus of CA. In contrast to the D50A mutant,
Western blots analyzing the P1A, T54A, and D57A M-PMV mutants
revealed the presence of truncated CA protein in addition to the
extended CA-related Gag cleavage products. Similarly, von Schwedler
et al. (1998) observed multiple bands indicating a series of truncated
p24CA molecules in released HIV-1 virions with D51A CA.
Mutational analyses of the N-terminal proline and its aspartate
partner in HIV-1 (von Schwedler et al., 1998; Abdurahman et al., 2007;
Leschonsky et al., 2007), MLV (Mortuza et al., 2004), MoMLV
(Auerbach et al., 2007), and HTLV-1 (Bouamr et al., 2005; Rayne
et al., 2001) showed the importance of the β-hairpin structure for
stability, proper core formation and infectivity. Similarly, we describe
here that both P1 and D57mutations of M-PMV CA abolished the virusinfectivity in 293T and COS-1 cells. EM analysis of the P1 and D57
mutants revealed aberrant cores in bothmutant VLPs. The observation
that although the P1Y, D50A, and T54A mutants exhibited reduced
infectivity without impairing the processing, virus release and the
mature core formation is puzzling. As the origin of reduced infectivity
remains unclear and there is no detectable alteration in the virus life
cycle, we can only speculate that the reasons could be e.g. an altered
stability of themature core, as reported for HIV-1 (Forshey et al., 2002)
or a lack of some stabilization host cell factor.
Several pieces of evidence for the functional role of the conserved
aspartate residues stabilizing the salt bridge between Pro1 and Asp of
theCA-NTDareavailable (Bouamret al., 2005;Mortuza et al., 2004; von
Schwedler et al.,1998; von Schwedler et al., 2003). Bouamr et al. (2005)
showed that D54A mutation in HTLV-1 CA did prevent neither correct
proteolytic processing nor particle size andmorphology. This contrasts
to both HIV and M-PMV, where the D51A and D57A mutations,
respectively, dramatically affected Gag polyprotein processing, core
formation and infectivity. The D63A mutation of MMLV CA had also a
dramatic effect on viral replication however, the infectivity and the
capsid core formationwere not studied in details (von Schwedler et al.,
1998). Nevertheless, these data suggests a correlation of improper Gag
cleavagewithmore dramatic changes inducing formation of differently
shaped mature cores i.e. conical in lentiviruses (HIV-1), tubular in
betaretroviruses (M-PMV) and spherical in gamma- and deltaretro-
viruses (MLV and HTLV-1, respectively). This is also in agreement with
the observation that a block of the salt-bridge formation bymasking of
the Pro1 by short extensions of CA amino terminus i.e. four amino acids
in HIV (von Schwedler et al., 1998; Gross et al., 1998), one in M-PMV
(Rumlova-Klikova et al., 2000) and25 in RSV (Nandhagopal et al., 2004)
can switch the formation of tubular particles to the spherical. The fact
that the assembly of spherical particles occurs also in the absence of
β-hairpin indicates that the formation of a spherical core could be
preferential to the formation of cones or tubes.
Materials and methods
Viral construct
All DNAmanipulations were carried out using standard subcloning
techniques, and plasmids were propagated in E. coli DH5α . All newly
created constructs were veriﬁed by DNA sequencing. For cloning of
viral constructs carrying point mutations a helper plasmid prepared
by ligation of a SacI–PstI fragment corresponding to nucleotides 1163
to 3859 of M-PMV into SacI–NsiI pGEMEX-2 (Promega) was used as a
template for oligonucleotide-directed mutagenesis. Primers were as
follows 5′-CAAAAGATATTTTCGCCGTGACTGAAACC-3′ for introducing
the P1A mutation, 5′-CAAAAGATATTTTCTATGTGACTGAAACC-3′ for
P1Y, 5′-GGGGTAAGCCAATTAGCCGCTACAGATTCC-3′ for D50A, 5′-GGA-
CAATTGGCTTGCCCCTACAGATTGG-3′ for T54A and 5′-TTACCCCTACAG-
CATGGAATACGC-3′ for D57A. SacI–Eco72I fragments of the helper
plasmid carrying the point mutation within CA were ligated into the
M-PMV proviral expression vector pSARM4.
For the infectivity assay the engineered M-PMV constructs were
cloned into pSARM-EGFP via SacI and Eco72I (Newman et al., 2006).
Cell growth and virus production
COS-1 cells were grown in Dulbecco's modiﬁed Eagle medium
(DMEM, Sigma) supplemented with 10% fetal bovine serum (Gibco)
and 1% L-glutamine (PAA Laboratories, Linz, Austria). COS-1 cells were
transfected with wild-type or mutant proviral DNA using Fugene 6
transfection reagent (Roche Molecular Biochemicals) according to the
manufacturer's instructions. Supernatants were harvested 24, 48 or
72 h post-transfection and the viral pellet was obtained by centrifuga-
tion at 200,000xg for 1 h in a Beckman SW41Ti rotor. Protein expression
was quantiﬁed using reverse transcriptase assay (RT) or Western blot.
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COS-1 cells transfected with the appropriate DNA were grown for
48 h post-transfection, starved for 30 min in methionine and cysteine
deﬁcient DMEM (Sigma) and then pulse-labeled for 30 min with
125 µCi/ml of Tran35S label (M.G.P., Czech Republic). The labeled cells
were chased for an appropriate period of time. The cells from pulse
and pulse–chase experiments were washed with cold phosphate-
buffered saline (PBS), lysed in 1 ml of lysis buffer A (1% Triton X-100,
1% sodium deoxycholate, 0.05 M NaCl, 25 mM Tris, pH 8.0) on ice for
20 min and clariﬁed by centrifugation at 13,000 ×g for 1 min. The
culture medium of the chased cells was ﬁltered through a 0.45 µm
ﬁlter and SDS was added to a ﬁnal concentration of 0.1%. Viral proteins
were immunoprecipitated from the cells and culture media with a
polyclonal rabbit anti-M-PMV CA antibody (dilution 1:1000) and
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
Radiolabeled protein bands were quantiﬁed on a Packard Cyclone™
system using OptiQuant™ software (Perkin Elmer, Shelton, CT).
Isolation of the virus
VLPs released from the COS-1 cells expressing wild-type, P1A, or
D57Amutants were ﬁltered from themedia through a 45 µm ﬁlter and
concentrated by sedimentation onto a 1 ml 60% iodixanol cushion at
35,000 ×g for 1 h in a Beckman SW41Ti rotor. Supernatant containing
VLPs from about 0.5 cm above the cushion was removed and layered
onto a 10–40% of iodixanol gradient and centrifuged for 16 h at
35,000 ×g in a Beckman SW41Ti rotor. Individual fractions were
analyzed by Western blot using anti-CA antibody.
Infectivity assay
COS-1 and 293T cells were transfected with both pSARM-EGFP,
expressing either wild-type or mutant M-PMV gag-EGFP gene, and
pTM0, expressing the M-PMV envelope glycoproteins (Newman et al.,
2006; Brody and Hunter, 1992). Culture medium was harvested 48 h
post-transfection, ﬁltrated through a 0.45 µm ﬁlter, stabilized by
addition of polybrene to a ﬁnal concentration of 8 µg/ml, and analyzed
for RT activity. Normalized amounts of virions from the RT activity
assay were used for infection of COS-1 cells. After 2 h incubation the
volume of the media was adjusted to 4 ml by complete DMEM and the
cells were incubated for an additional 24, 48 or 72 h. The cells were
ﬁxed with 3% formaldehyde and the number of GFP positive cells was
determined by ﬂow cytometry (BD FACSaria).
Reverse transcriptase assay
Virions from 4 ml of ﬁltered culture supernatant were pelleted by
centrifugation at 200,000 ×g in a Beckman SW41Ti rotor for 1 h and
the pellet was resuspended in 50 µl of buffer L (50 mM Tris pH 8,
100 mM KCl, 0.05% Nonidet NP-40, 2 mM DTT). The ﬁnal RT sample
consisted of 50 mM Tris pH 8, 90 mM KCl, 8 mMMgCl2, 0.05% Nonidet
NP-40, 0.3 µg dA oligo, 0.6 µg poly rU, 20 mM DTT and 10 µCi α33P
dATP. 10 µl of lysed virions was mixed with 40 µl of reaction mixture
and incubated at 37 °C for 1 h. 5 µl was spotted on Whatman DE-81
paper, washed with SSC buffer (1.5 mM sodium citrate buffer pH 7 and
150 mM NaCl) and analyzed with a Typhoon Phosphoimager.
Western blotting
COS-1 cells were transfected with wild-type or mutant proviral
constructs. Culture supernatant was harvested 48 h post-transfection,
ﬁltered through a 0.45-µm ﬁlter, and ultracentrifuged through a 20%
sucrose cushion for 1 h at 200,000 ×g in a Beckman SW41Ti rotor. The
pellet was resuspended in protein loading buffer and the proteins
were separated by SDS-PAGE and blotted onto a nitrocellulosemembrane. Membrane-bound CA-related proteins were immunode-
tected with a rabbit anti-M-PMV CA, MA, dUTPase, PR, IN and RT
polyclonal antibodies. The blots were then incubated with secondary
HRP-conjugated antibody and developed by chemiluminescent sub-
strate (Pierce).
Electron microscopy of tissue culture cells
COS-1 cells transiently expressing the wild-type or mutant M-PMV
proviral constructs grown on 60 mm plastic dishes were washed three
times with PBS, scraped into a microtube and preﬁxed with freshly
prepared 2.5% glutaraldehyde in 0.1 M cacodylate buffer pH 7.5. After
washingwith 0.1M cacodylate buffer pH 7.5 the cells were postﬁxed in
1%osmium tetroxide, dehydrated in anethanol series (30, 50, 70, 80, 90,
and 100%) and embedded in fresh EMBED 812 or AGAR 100 epoxy resin
in a labeled Beem capsule. Ultrathin sections (70 nm) of cells were cut
with a diamondknife on a RMCMT7000Ultramicrotomeandplaced on
200-mesh copper grids. The sections were contrasted with uranyl
acetate and lead citrate. A JEOL JEM-1200EX analytical transmission
electron microscope operated at 60 kV was used for analysis.Acknowledgments
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